デフォルト表紙
市場調査レポート
商品コード
1462911

間葉系幹細胞(MSC)市場:製品タイプ別、最終用途別、国別、地域別-2024-2032年の産業分析、市場規模、市場シェア、予測

Mesenchymal Stem Cells Market, By Product Type, By Application, By End-Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 310 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
間葉系幹細胞(MSC)市場:製品タイプ別、最終用途別、国別、地域別-2024-2032年の産業分析、市場規模、市場シェア、予測
出版日: 2024年04月04日
発行: AnalystView Market Insights
ページ情報: 英文 310 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートのハイライト

間葉系幹細胞市場規模は2023年に34億5,400万米ドルとなり、2024年から2032年にかけてCAGR 11.5%で拡大

間葉系幹細胞市場-市場力学

再生医療への嗜好が市場需要を促進

間葉系幹細胞は、再生医療分野において非常に有用なツールとなっています。間葉系幹細胞は、歯髄、脂肪組織、骨髄、臍帯など多くの組織から抽出することができます。MSCは様々な組織型に分化する能力を持ち、免疫調節の資質を持つため、損傷や変性した組織の修復に使用されることが増え、市場は大きく支えられています。組織損傷や慢性疾患に対する効率的な治療法の必要性が高まっていることから、再生医療市場は近い将来拡大すると予想されます。さらに、骨折、軟骨変形、靭帯損傷、腱損傷の治癒を助けるためにMSCが広く使用されていることも、この業界にプラスの影響を与えています。MSCを損傷部位に直接注入することで、組織再生を促進し、炎症を抑え、結果を改善し、治癒プロセスを早めることが可能です。MSCに基づく治療は、高齢化社会と筋骨格系障害の有病率の上昇に伴い、整形外科でますます普及すると予測されています。

間葉系幹細胞市場-主要インサイト

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間(2024-2032年)に約11.5%のCAGRで毎年成長すると予測されています。

製品タイプ別では、骨髄セグメントが予測期間中市場を独占すると予測されています。

用途別では、治療分野が予測期間中に市場の成長をリードすると予測されています。

地域別では、北米が2023年の売上高をリードするとされています。

間葉系幹細胞市場-セグメンテーション分析:

間葉系幹細胞の世界市場は、製品タイプ、用途、最終用途、地域に基づいてセグメント化されます。

製品タイプ別では、脂肪組織、骨髄、臍帯、その他に分類されます。予測期間中、骨髄セグメントが市場を独占すると予想されます。骨髄由来の間葉系幹細胞は多くの研究の対象となっており、その分野では最高と考えられています。これらの細胞は、脂肪細胞、軟骨細胞、骨芽細胞などの様々な細胞型に分化する能力を有しています。この特徴により、炎症性疾患や免疫疾患、整形外科的疾患や筋骨格系疾患の管理など、幅広い治療への応用が可能です。さらに、間葉系幹細胞は骨髄から頻繁に採取できるため、科学者や医療従事者にとって人気のある選択肢となっています。

用途別では、研究、治療、その他に分けられます。予測期間中、治療セグメントが市場成長をリードすると予想されています。MSCは、火傷、自己免疫疾患、心臓や神経の問題、骨や軟骨の異常、自己免疫疾患など、様々な病気や外傷の治療において有望な結果を示しています。より多くの臨床試験や学術研究がその安全性と有効性を実証するにつれ、MSCは再生医療においてますます使用されるようになってきています。さらに、糖尿病やがんなどの慢性疾患の罹患率が上昇していることから、MSCを用いた治療法の需要が増加すると予想されています。

最終用途では、筋骨格系、整形外科、腫瘍学、心臓血管、その他に分けられます。

間葉系幹細胞市場-地理的洞察

地理的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスを展開する国によってさらに分けられます。北米は予測期間中、市場シェアの大半を占めると予想されています。米国では、様々な重篤な疾患に対する治療法として間葉系幹細胞の安全性と有効性を評価するため、数多くの臨床試験が実施されています。実際、北米には間葉系幹細胞の供給と商業化に携わる大企業のかなりの部分が存在します。新たな治療法に対するニーズの高まり、政府の奨励的な政策、慢性疾患治療のための洗練された間葉系幹細胞治療法を開発しようとする業界関係者の努力の高まりがあります。これらの要素が、この地域の商業的優位性に一役買っています。

間葉系幹細胞市場-競合情勢:

市場の主要企業は、Takeda Pharmaceutical Company Limited、Merck KGaA、Thermo Fisher Scientific, Inc.、Lonza Group Ltd、Stemcell Technologies, Inc.Cellular Dynamics International, Inc.Regeneus、Tissue Genesis、Cesca Therapeutics、Ipsen。これらのプレーヤーは、製品発売、事業拡大、投資、提携など様々な戦略を採用し、市場の最大シェアを獲得しています。

目次

第1章 間葉系幹細胞市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 間葉系幹細胞の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 間葉系幹細胞産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 間葉系幹細胞市場: COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 間葉系幹細胞市場情勢

  • 間葉系幹細胞市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 間葉系幹細胞市場-製品タイプ別

  • 概要
    • 製品タイプ別セグメントシェア分析
    • 脂肪組織
    • 骨髄
    • へその緒
    • その他

第8章 間葉系幹細胞市場- 用途別

  • 概要
    • 用途別セグメントシェア分析
    • 調査
    • 治療
    • その他

第9章 間葉系幹細胞市場- 最終用途別

  • 概要
    • 最終用途別セグメントシェア分析
    • 病院
    • 筋骨格
    • 整形外科
    • 腫瘍学
    • 心臓血管
    • その他

第10章 間葉系幹細胞市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋(APAC)
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- 間葉系幹細胞業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Takeda Pharmaceutical Company Limited
    • Merck KGaA
    • Thermo Fisher Scientific, Inc.
    • Lonza Group Ltd
    • Stemcell Technologies, Inc.
    • Cellular Dynamics International, Inc.
    • Regeneus Ltd
    • Tissue Genesis, Inc.
    • Cesca Therapeutics Inc
    • Ipsen

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Mesenchymal Stem Cells Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Mesenchymal Stem Cells Market, by Product Type 2019-2032 (USD Million)
  • TABLE Mesenchymal Stem Cells Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Mesenchymal Stem Cells Market, by Application 2019-2032 (USD Million)
  • TABLE Mesenchymal Stem Cells Market: End-UseSnapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-Use
  • TABLE Global Mesenchymal Stem Cells Market, by End-Use2019-2032 (USD Million)
  • TABLE Mesenchymal Stem Cells Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Mesenchymal Stem Cells Market, by Region 2019-2032 (USD Million)
  • TABLE North America Mesenchymal Stem Cells Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Mesenchymal Stem Cells Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America Mesenchymal Stem Cells Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Mesenchymal Stem Cells Market, by End-Use, 2019-2032 (USD Million)
  • TABLE Europe Mesenchymal Stem Cells Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Mesenchymal Stem Cells Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe Mesenchymal Stem Cells Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Mesenchymal Stem Cells Market, by End-Use, 2019-2032 (USD Million)
  • TABLE Asia Pacific Mesenchymal Stem Cells Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Mesenchymal Stem Cells Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Mesenchymal Stem Cells Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Mesenchymal Stem Cells Market, by End-Use, 2019-2032 (USD Million)
  • TABLE Latin America Mesenchymal Stem Cells Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Mesenchymal Stem Cells Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America Mesenchymal Stem Cells Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Mesenchymal Stem Cells Market, by End-Use, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Mesenchymal Stem Cells Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Mesenchymal Stem Cells Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Mesenchymal Stem Cells Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Mesenchymal Stem Cells Market, by End-Use, 2019-2032 (USD Million)
目次
Product Code: ANV2369

REPORT HIGHLIGHT

Mesenchymal Stem Cells Market size was valued at USD 3,454 Million in 2023, expanding at a CAGR of 11.5% from 2024 to 2032.

Within the field of regenerative medicine, adult stem cells known as mesenchymal stem cells (MSCs) exhibit great potential. Bone marrow, adipose tissue (fat), umbilical cord blood, and dental pulp are among the tissues in the body that contain them. Osteoblasts, chondrocytes, myocytes, fat cells, and muscle cells are just a few of the cell types that can be created from MSCs because to their amazing capacity to differentiate.

Mesenchymal Stem Cells Market- Market Dynamics

Preference for regenerative medicine to propel market demand

MSCs have become a very useful tool in the field of regenerative medicine. They can be extracted from a number of tissues, such as tooth pulp, adipose tissue, bone marrow, and umbilical cord. The market is being substantially supported by the increasing use of MSCs for the repair of damaged or degenerated tissues because of their capacity to differentiate into a variety of tissue types and their immunomodulatory qualities. Given the rising need for efficient therapies for tissue damage and chronic illnesses, the market for regenerative medicine is expected to expand in the near future. Furthermore, the industry is being positively impacted by the widespread use of MSCs to aid in the healing of fractures, cartilage deformities, ligament injuries, and tendon injury. It is feasible to promote tissue regeneration and decrease inflammation by injecting MSCs directly into the injured area, improving results and hastening the healing process. MSC-based therapies are predicted to become increasingly popular in orthopedics as the aging population and the prevalence of musculoskeletal disorders rise.

Mesenchymal Stem Cells Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.5% over the forecast period (2024-2032)

Based on product type segmentation, the Bone Marrow segment is expected to dominate the market over the forecast period

Based on the application segmentation, the Therapeutic segment is expected to lead the market growth during the forecast period

Based on region, North America was the leading revenue generator in 2023

Mesenchymal Stem Cells Market- Segmentation Analysis:

The Global Mesenchymal Stem Cells Market is segmented based on Product Type, Application, End-Use, and Region.

Based on the product type, the market is categorized into Adipose Tissue, Bone Marrow, Umbilical Cord and Others. The Bone Marrow segment is expected to dominate the market over the forecast period. Bone marrow-derived mesenchymal stem cells have been the subject of much study and are considered the best in their area. These cells have the ability to differentiate into a variety of cell types, including adipocytes, chondrocytes, and osteoblasts. This characteristic enables its use in a wide range of therapeutic applications, such as the management of inflammatory and immunological diseases as well as orthopedic and musculoskeletal conditions. Moreover, mesenchymal stem cells may be obtained from bone marrow quite frequently, which makes it a popular choice for scientists and medical practitioners.

Based on the application, the market is divided into Research, Therapeutic and Others. The Therapeutic segment is expected to lead the market growth during the forecast period. MSCs have shown promising results in the treatment of a range of ailments and traumas, such as burns, autoimmune disorders, heart and neurological issues, anomalies of the bone and cartilage, and autoimmune diseases. MSCs are being used more and more in regenerative medicine as more clinical trials and scholarly research demonstrate their safety and efficacy. Furthermore, it is anticipated that the rising incidence of chronic illnesses like diabetes and cancer would increase demand for MSC-based therapies.

Based on the end-use, the industry is divided into Musculoskeletal, Orthopedics, Oncology, Cardiovascular and Others.

Mesenchymal Stem Cells Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to hold the majority of market share during the forecast period. In the United States, a significant number of clinical trials are being conducted to evaluate the safety and effectiveness of mesenchymal stem cells as a potential treatment for a range of serious illnesses. Moreover, North America is home to a sizable portion of the largest corporations involved in the supply and commercialization of MSCs. Furthermore, there is a growing need for novel treatments, encouraging government policies, and heightened endeavors by industry players to create sophisticated mesenchymal stem cell treatments for the treatment of chronic diseases. These elements have played a part in the region's commercial supremacy.

Mesenchymal Stem Cells Market- Competitive Landscape:

The key players in the market are Takeda Pharmaceutical Company Limited, Merck KGaA, Thermo Fisher Scientific, Inc., Lonza Group Ltd, Stemcell Technologies, Inc. Cellular Dynamics International, Inc. Regeneus Ltd, Tissue Genesis, Inc., Cesca Therapeutics Inc and Ipsen. These players adopted various strategies such as product launch, expansion, investment, collaboration, and others to obtain the maximum market share of the market.

Recent Developments:

In May 2023, through a collaboration with Histocell, REPROCELL will now provide CDMO services to produce Advanced Therapies Medicinal Products (ATMPs) made from mesenchymal stem cells (MSC). Histocell, a subcontracting partner of REPROCELL, has opened a GMP ATMP production plant in Bilbao, Spain, with authorization. Since2008, Histocell has been offering GMP manufacturing services. The company has extensive experience producing therapeutic MSC products, such as exosome cell treatments and cell-free MSC-derived secretome.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MESENCHYMAL STEM CELLS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Takeda Pharmaceutical Company Limited

Merck KGaA

Thermo Fisher Scientific, Inc.

Lonza Group Ltd

Stemcell Technologies, Inc.

Cellular Dynamics International, Inc.

Regeneus Ltd

Tissue Genesis, Inc.

Cesca Therapeutics Inc

Ipsen

GLOBAL MESENCHYMAL STEM CELLS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Adipose Tissue
  • Bone Marrow
  • Umbilical Cord
  • Others

GLOBAL MESENCHYMAL STEM CELLS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Research
  • Therapeutic
  • Others

GLOBAL MESENCHYMAL STEM CELLS MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

  • Musculoskeletal
  • Orthopedics
  • Oncology
  • Cardiovascular
  • Others

GLOBAL MESENCHYMAL STEM CELLS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Mesenchymal Stem Cells Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Mesenchymal Stem Cells Market Snippet by Product Type
    • 2.1.2.Mesenchymal Stem Cells Market Snippet by Application
    • 2.1.3.Mesenchymal Stem Cells Market Snippet by End-Use
    • 2.1.4.Mesenchymal Stem Cells Market Snippet by Country
    • 2.1.5.Mesenchymal Stem Cells Market Snippet by Region
  • 2.2.Competitive Insights

3.Mesenchymal Stem Cells Key Market Trends

  • 3.1.Mesenchymal Stem Cells Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Mesenchymal Stem Cells Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Mesenchymal Stem Cells Market Opportunities
  • 3.4.Mesenchymal Stem Cells Market Future Trends

4.Mesenchymal Stem Cells Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Mesenchymal Stem Cells Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Mesenchymal Stem Cells Market Landscape

  • 6.1.Mesenchymal Stem Cells Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Mesenchymal Stem Cells Market - By Product Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2.Adipose Tissue
    • 7.1.3.Bone Marrow
    • 7.1.4.Umbilical Cord
    • 7.1.5.Others

8.Mesenchymal Stem Cells Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Research
    • 8.1.3.Therapeutic
    • 8.1.4.Others

9.Mesenchymal Stem Cells Market - By End-Use

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By End-Use, 2023 & 2032 (%)
    • 9.1.2.Hospitals
    • 9.1.3.Musculoskeletal
    • 9.1.4.Orthopedics
    • 9.1.5.Oncology
    • 9.1.6.Cardiovascular
    • 9.1.7.Others

10.Mesenchymal Stem Cells Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.Mesenchymal Stem Cells Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.Mesenchymal Stem Cells Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.Mesenchymal Stem Cells Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.Mesenchymal Stem Cells Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.Mesenchymal Stem Cells Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Mesenchymal Stem Cells Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.Takeda Pharmaceutical Company Limited
    • 11.2.2.Merck KGaA
    • 11.2.3.Thermo Fisher Scientific, Inc.
    • 11.2.4.Lonza Group Ltd
    • 11.2.5.Stemcell Technologies, Inc.
    • 11.2.6.Cellular Dynamics International, Inc.
    • 11.2.7.Regeneus Ltd
    • 11.2.8.Tissue Genesis, Inc.
    • 11.2.9.Cesca Therapeutics Inc
    • 11.2.10.Ipsen

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research End-Useology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us